验证数据展示
经过测试的应用
Positive IF-P detected in | human liver tissue |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-66753 targets Factor X in IF-P applications and shows reactivity with Human samples.
经测试应用 | IF-P Application Description |
经测试反应性 | Human |
免疫原 | Factor X fusion protein Ag11664 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | coagulation factor X |
别名 | coagulation factor X, F10, FX, FXA, Stuart factor, Stuart Prower factor |
计算分子量 | 488 aa, 55 kDa |
观测分子量 | 50 kDa |
GenBank蛋白编号 | BC046125 |
基因名称 | F10 |
Gene ID (NCBI) | 2159 |
RRID | AB_2934494 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | P00742 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Coagulation factor X (F10) is a vitamin K-dependent glycoprotein that participates in the middle phase of the blood coagulation cascade (PMID: 1931959; 1313796). It is synthesized as a single-chain precursor in the liver where it undergoes a number of covalent processing steps before secretion into the blood as a two-chain molecule linked by a disulfide bond (PMID: 1313796). The light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. Factor X is activated into factor Xa, by both the extrinsic and intrinsic pathway. The activated factor then converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 Factor X antibody CL488-66753 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |